BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 19419270)

  • 21. Microbiological screening is necessary to distinguish carriers of plasmid-mediated AmpC beta-lactamase-producing enterobacteriaceae and extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae because of clinical similarity.
    Conen A; Frei R; Adler H; Dangel M; Fux CA; Widmer AF
    PLoS One; 2015; 10(3):e0120688. PubMed ID: 25803720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous occurrence of MRSA and ESBL-producing Enterobacteriaceae on pig farms and in nasal and stool samples from farmers.
    Fischer J; Hille K; Ruddat I; Mellmann A; Köck R; Kreienbrock L
    Vet Microbiol; 2017 Feb; 200():107-113. PubMed ID: 27328620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extended-spectrum beta-lactamase-producing Enterobacteriaceae carriage upon hospital admission: prevalence and risk factors.
    Shitrit P; Reisfeld S; Paitan Y; Gottesman BS; Katzir M; Paul M; Chowers M
    J Hosp Infect; 2013 Nov; 85(3):230-2. PubMed ID: 24080081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for colonization with extended-spectrum beta-lactamase-producing enterobacteriaceae on admission to rehabilitation centres.
    Bilavsky E; Temkin E; Lerman Y; Rabinovich A; Salomon J; Lawrence C; Rossini A; Salvia A; Samso JV; Fierro J; Paul M; Hart J; Gniadkowski M; Hochman M; Kazma M; Klein A; Adler A; Schwaber MJ; Carmeli Y;
    Clin Microbiol Infect; 2014 Nov; 20(11):O804-10. PubMed ID: 24674024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of tigecycline against extended-spectrum β-lactamase-producing Enterobacteriaceae and MRSA clinical isolates from Mexico: a multicentric study.
    Silva-Sanchez J; Reyna-Flores F; Velazquez-Meza ME; Rojas-Moreno T; Benitez-Diaz A; Sanchez-Perez A;
    Diagn Microbiol Infect Dis; 2011 Jun; 70(2):270-3. PubMed ID: 21596226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extended-spectrum β-lactamase-producing Enterobacteriaceae in Cameroonian hospitals.
    Lonchel CM; Melin P; Gangoué-Piéboji J; Assoumou MC; Boreux R; De Mol P
    Eur J Clin Microbiol Infect Dis; 2013 Jan; 32(1):79-87. PubMed ID: 22886058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence, risk factors and genetic characterisation of extended-spectrum beta-lactamase and carbapenemase-producing Enterobacteriaceae (ESBL-E and CPE): a community-based cross-sectional study, the Netherlands, 2014 to 2016.
    van den Bunt G; van Pelt W; Hidalgo L; Scharringa J; de Greeff SC; Schürch AC; Mughini-Gras L; Bonten MJM; Fluit AC
    Euro Surveill; 2019 Oct; 24(41):. PubMed ID: 31615600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and acceptability of rectal and perineal sampling for identifying gastrointestinal colonization with extended spectrum β-lactamase Enterobacteriaceae.
    Dyakova E; Bisnauthsing KN; Querol-Rubiera A; Patel A; Ahanonu C; Tosas Auguet O; Edgeworth JD; Goldenberg SD; Otter JA
    Clin Microbiol Infect; 2017 Aug; 23(8):577.e1-577.e3. PubMed ID: 28242273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ICU Acquisition Rate, Risk Factors, and Clinical Significance of Digestive Tract Colonization With Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae: A Systematic Review and Meta-Analysis.
    Detsis M; Karanika S; Mylonakis E
    Crit Care Med; 2017 Apr; 45(4):705-714. PubMed ID: 28157141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae in HIV-infected children in Zimbabwe.
    Wilmore SMS; Kranzer K; Williams A; Makamure B; Nhidza AF; Mayini J; Bandason T; Metcalfe J; Nicol MP; Balakrishnan I; Ellington MJ; Woodford N; Hopkins S; McHugh TD; Ferrand RA
    J Med Microbiol; 2017 May; 66(5):609-615. PubMed ID: 28513417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of rates of fecal colonization with extended-spectrum beta-lactamase-producing enterobacteria among patients in different wards, outpatients and medical students.
    Ebrahimi F; Mózes J; Monostori J; Gorácz O; Fésűs A; Majoros L; Szarka K; Kardos G
    Microbiol Immunol; 2016 May; 60(5):285-94. PubMed ID: 26959958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical profiles of patients colonized or infected with extended-spectrum beta-lactamase producing Enterobacteriaceae isolates: a 20 month retrospective study at a Belgian University Hospital.
    Schoevaerdts D; Bogaerts P; Grimmelprez A; de Saint-Hubert M; Delaere B; Jamart J; Swine C; Glupczynski Y
    BMC Infect Dis; 2011 Jan; 11():12. PubMed ID: 21226923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective observational study of the prevalence and risk factors for colonization by antibiotic resistant bacteria in patients at admission to hospital in Singapore.
    Young BE; Lye DC; Krishnan P; Chan SP; Leo YS
    BMC Infect Dis; 2014 Jun; 14():298. PubMed ID: 24889720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital.
    Ben-Ami R; Schwaber MJ; Navon-Venezia S; Schwartz D; Giladi M; Chmelnitsky I; Leavitt A; Carmeli Y
    Clin Infect Dis; 2006 Apr; 42(7):925-34. PubMed ID: 16511754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carrier prevalence and risk factors for colonisation of multiresistant bacteria in Danish emergency departments: a cross-sectional survey.
    Skjøt-Arkil H; Mogensen CB; Lassen AT; Johansen IS; Chen M; Petersen P; Andersen KV; Ellermann-Eriksen S; Møller JM; Ludwig M; Fuglsang-Damgaard D; Nielsen FE; Petersen DB; Jensen US; Rosenvinge FS
    BMJ Open; 2019 Jun; 9(6):e029000. PubMed ID: 31253624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology and risk factors for faecal extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) carriage derived from residents of seven nursing homes in western Shanghai, China.
    Zhao SY; Zhang J; Zhang YL; Wang YC; Xiao SZ; Gu FF; Guo XK; Ni YX; Han LZ
    Epidemiol Infect; 2016 Mar; 144(4):695-702. PubMed ID: 26260355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two-year prospective evaluation of colonization with extended-spectrum beta-lactamase-producing Enterobacteriaceae: time course and risk factors.
    Papst L; Beović B; Seme K; Pirš M
    Infect Dis (Lond); 2015 Sep; 47(9):618-24. PubMed ID: 25865350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carriage of Extended-spectrum Beta-lactamase-producing Enterobacteriaceae and the Risk of Surgical Site Infection After Colorectal Surgery: A Prospective Cohort Study.
    Dubinsky-Pertzov B; Temkin E; Harbarth S; Fankhauser-Rodriguez C; Carevic B; Radovanovic I; Ris F; Kariv Y; Buchs NC; Schiffer E; Cohen Percia S; Nutman A; Fallach N; Klausner J; Carmeli Y;
    Clin Infect Dis; 2019 May; 68(10):1699-1704. PubMed ID: 30204851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rates of fecal transmission of extended-spectrum β-lactamase-producing and carbapenem-resistant Enterobacteriaceae among patients in intensive care units in Korea.
    Kim J; Lee JY; Kim SI; Song W; Kim JS; Jung S; Yu JK; Park KG; Park YJ
    Ann Lab Med; 2014 Jan; 34(1):20-5. PubMed ID: 24422191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common.
    Frazee BW; Trivedi T; Montgomery M; Petrovic DF; Yamaji R; Riley L
    Ann Emerg Med; 2018 Oct; 72(4):449-456. PubMed ID: 29980462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.